Amgen (AMGN) Asset Utilization Ratio (2009 - 2026)

Amgen (AMGN) recorded quarterly Asset Utilization Ratio of 0.41 in Q1 2026, little changed quarter-over-quarter from 0.41 in Q4 2025, and up 7.94% on a YoY basis from 0.38 in Q1 2025.

Amgen (AMGN) Asset Utilization Ratio (2009 - 2026) Analysis & Trends

Amgen's Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.41 for Q1 2026.

  • In Q1 2026, Asset Utilization Ratio rose 7.94% year-over-year to 0.41; the TTM figure through Mar 2026 stood at 0.41 (up 7.94% YoY), while the FY2025 annual figure was 0.4, up 13.91% from the prior year.
  • Asset Utilization Ratio was 0.41 for Q1 2026 at Amgen, roughly flat from 0.41 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.45 in Q2 2022 to a low of 0.23 in Q2 2023.
  • Historically, Asset Utilization Ratio has averaged 0.35 across 5 years, with a median of 0.37 in 2024.
  • The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio slumped 49.31% in 2023, then jumped 58.2% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.31 in 2022, then decreased by 2.98% to 0.3 in 2023, then rose by 21.79% to 0.37 in 2024, then grew by 11.17% to 0.41 in 2025, then declined by 0.03% to 0.41 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.41 (Q1 2026), 0.41 (Q4 2025), and 0.4 (Q3 2025), per Business Quant data.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 0.53
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 0.63
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 0.48
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 0.46
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 0.50
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 0.41
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 0.52
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 0.12
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 0.55
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 0.41
Dec 31, 2025 0.41
Sep 30, 2025 0.40
Jun 30, 2025 0.39
Mar 31, 2025 0.38
Dec 31, 2024 0.37
Sep 30, 2024 0.36
Jun 30, 2024 0.34
Mar 31, 2024 0.31
Dec 31, 2023 0.30
Sep 30, 2023 0.23
Jun 30, 2023 0.23
Mar 31, 2023 0.26
Dec 31, 2022 0.31
Sep 30, 2022 0.43
Jun 30, 2022 0.45
Mar 31, 2022 0.44
Dec 31, 2021 0.41
Sep 30, 2021 0.41
Jun 30, 2021 0.41